Breyer Capital is a global venture capital firm headquartered in Austin, with additional presence in Menlo Park, that invests across AI, healthcare, and frontier technology. The firm is known for backing high-impact founders and maintaining a long-term approach to company building.

Its portfolio spans major technology and life science companies, and it is particularly relevant where artificial intelligence intersects with healthcare and biology. While not a neurotech-only fund, it is a strong fit for companies using AI to unlock new capabilities in diagnostics, therapeutics, or cognitive health.

The firm invests globally, with strongest presence in the United States and selected international hubs. For neurotech founders, Breyer Capital is most relevant where the company combines scientific differentiation with large-scale platform potential.